| Ramesh Prajapati, MD | |
|
10557 Stonegate Dr, Fishers, IN 46040-9433 | |
| (347) 981-4529 | |
| Not Available |
| Full Name | Ramesh Prajapati |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 18 Years |
| Location | 10557 Stonegate Dr, Fishers, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245661859 | NPI | - | NPPES |
| 000000976734 | Other | IN | ANTHEM |
| 201233910 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01073995A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health Ball Memorial Hospital | Muncie, IN | Hospital |
| Indiana University Health | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Ball Memorial Physicians Inc | 9537072640 | 297 |
News Archive
An electronic biosensor powered using the glucose in bodily fluids has been developed by KAUST researchers. The device pairs an electron-transporting polymer with an enzyme that extracts electrons from its reaction with glucose to drive its circuitry.
A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
A leading expert on sleep and insomnia is giving a free public lecture in Birmingham on Wednesday 30 November 2011.
› Verified 2 days ago
| Entity Name | Indiana University Health Ball Memorial Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235455544 PECOS PAC ID: 9537072640 Enrollment ID: O20031110000505 |
News Archive
An electronic biosensor powered using the glucose in bodily fluids has been developed by KAUST researchers. The device pairs an electron-transporting polymer with an enzyme that extracts electrons from its reaction with glucose to drive its circuitry.
A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
A leading expert on sleep and insomnia is giving a free public lecture in Birmingham on Wednesday 30 November 2011.
› Verified 2 days ago
| Entity Name | Reid Physician Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265689111 PECOS PAC ID: 6406910769 Enrollment ID: O20090130000573 |
News Archive
An electronic biosensor powered using the glucose in bodily fluids has been developed by KAUST researchers. The device pairs an electron-transporting polymer with an enzyme that extracts electrons from its reaction with glucose to drive its circuitry.
A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
A leading expert on sleep and insomnia is giving a free public lecture in Birmingham on Wednesday 30 November 2011.
› Verified 2 days ago
| Entity Name | Sound Physicians Of Indiana, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528311149 PECOS PAC ID: 4981841780 Enrollment ID: O20130515000624 |
News Archive
An electronic biosensor powered using the glucose in bodily fluids has been developed by KAUST researchers. The device pairs an electron-transporting polymer with an enzyme that extracts electrons from its reaction with glucose to drive its circuitry.
A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
A leading expert on sleep and insomnia is giving a free public lecture in Birmingham on Wednesday 30 November 2011.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of Indiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720416555 PECOS PAC ID: 7719119965 Enrollment ID: O20140422001842 |
News Archive
An electronic biosensor powered using the glucose in bodily fluids has been developed by KAUST researchers. The device pairs an electron-transporting polymer with an enzyme that extracts electrons from its reaction with glucose to drive its circuitry.
A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
A leading expert on sleep and insomnia is giving a free public lecture in Birmingham on Wednesday 30 November 2011.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ramesh Prajapati, MD 10557 Stonegate Dr, Fishers, IN 46040-9433 Ph: (347) 981-4529 | Ramesh Prajapati, MD 10557 Stonegate Dr, Fishers, IN 46040-9433 Ph: (347) 981-4529 |
News Archive
An electronic biosensor powered using the glucose in bodily fluids has been developed by KAUST researchers. The device pairs an electron-transporting polymer with an enzyme that extracts electrons from its reaction with glucose to drive its circuitry.
A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
A leading expert on sleep and insomnia is giving a free public lecture in Birmingham on Wednesday 30 November 2011.
› Verified 2 days ago
Dr. Michele J Ostrowski, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7199 Easy St, Fishers, IN 46038 Phone: 317-415-6110 | |
Tammy N Durham-boring, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 9894 E 121st St, Fishers, IN 46037 Phone: 317-621-6060 Fax: 317-355-6965 | |
Racquel Kukita Reyes, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7199 Easy St, Fishers, IN 46038 Phone: 317-415-6110 | |
Anna Marie C Sander, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 12677 Brookhaven Dr, Fishers, IN 46037 Phone: 317-219-5188 | |
Dr. Derrick A Williams, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 13914 Southeastern Parkway, Suite 210, Fishers, IN 46037 Phone: 317-419-9900 Fax: 317-415-9910 | |
Sridevi A Vedantam, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10318 Copper Ridge Dr, Fishers, IN 46040 Phone: 765-965-6566 | |
Dr. Peter Caccavallo, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13000 E 136th St, Suite 1100, Fishers, IN 46037 Phone: 317-678-3585 Fax: 317-863-5084 |